RxDoctor Payments Data

Jenna Harkins, NP

Family · Exton, PANPI 1750821377

Payments from drug & device makers

$6,859in general payments, 2019–2025

Across 398 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Pfizer$611
  • Collegium Pharmaceutical, Inc.$560
  • Scilex Pharmaceuticals Inc.$405
  • IBSA Pharma Inc.$295
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$6,859100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,859 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$57,983
Medicare patients
121
Services billed
1,489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl170$129,534
RelistorMethylnaltrexone Bromide34$86,971
Xtampza ErOxycodone Myristate182$82,107
BelbucaBuprenorphine Hcl83$69,280
NucyntaTapentadol Hcl33$62,160
Nucynta ErTapentadol Hcl31$60,461
Oxycodone Hcl1,379$29,590
Nurtec OdtRimegepant Sulfate18$25,987
UbrelvyUbrogepant18$23,347
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen776$22,262
LinzessLinaclotide34$20,151
Buprenorphine50$16,943
MovantikNaloxegol Oxalate43$16,442
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen464$15,466
Fentanyl121$14,949

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta, Nucynta Er$560$274,009329 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor, Trulance$1,279$96,11351 claims
AbbVieUbrelvy, Linzess$1,358$43,49852 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Buprenorphine Hcl, Morphine Sulfate$18$41,765369 claims
PfizerNurtec Odt$611$25,98718 claims
Scilex Pharmaceuticals Inc.Ztlido$405$9,10019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.

Other family in Exton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →